# Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

> **NCT03092505** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 190 (actual)

## Conditions studied

- Herpes Virus-Related Illnesses

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03092505
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-15
- **Primary completion:** 2021-02-01
- **Final completion:** 2021-02-04
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03092505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03092505, "Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03092505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*